Cargando…
Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand
The lungs of tuberculosis (TB) patients contain a spectrum of granulomatous lesions, ranging from solid and well-vascularized cellular granulomas to avascular caseous granulomas. In solid granulomas, current therapy kills actively replicating (AR) intracellular bacilli, while in low-vascularized cas...
Autores principales: | Lanni, Alessio, Iacobino, Angelo, Fattorini, Lanfranco, Giannoni, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301435/ https://www.ncbi.nlm.nih.gov/pubmed/37375013 http://dx.doi.org/10.3390/microorganisms11061511 |
Ejemplares similares
-
Activity of Drug Combinations against Mycobacterium abscessus Grown in Aerobic and Hypoxic Conditions
por: Lanni, Alessio, et al.
Publicado: (2022) -
Moxifloxacin Activates the SOS Response in Mycobacterium tuberculosis in a Dose- and Time-Dependent Manner
por: Iacobino, Angelo, et al.
Publicado: (2021) -
Targeting Dormant Bacilli to Fight Tuberculosis
por: Fattorini, Lanfranco, et al.
Publicado: (2013) -
Mycobacterium tuberculosis Drug Resistance, Abkhazia
por: Pardini, Manuela, et al.
Publicado: (2005) -
Enigma of Extrapulmonary Tuberculosis: Where Do We Stand?
por: Inayat, Faisal, et al.
Publicado: (2017)